Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Navigating the Landscape of Drug Formularies and Prescribing and Treatment Guidelines
Over the course of the next several years we can expect more and more jurisdictions to move towards adoption of legislative and/or regulatory measures
Mitchell and Genex Services Finalize Merger
Merger establishes complete suite of medical compliance, cost containment and clinical solutions enhancing collective capabilities to create even
Mitchell Diagnostics System Surpasses Quarter Million Repair Scan Milestone; Freedom Platform Extended
SAN DIEGO, CA—Mitchell International, Inc., a leading provider of technology, connectivity and information solutions to the
Risk & Insurance: Starbucks' Workers' Comp Program Earns a Teddy Award for Its Exceptional Employee Advocacy
In just four years, Starbucks Coffee Company changed the way workers' comp claims were handled by placing the process in the hands of their p
Montana to Hold Hearing on Proposed Drug Formulary Rule
The Montana Department of Labor and Industry (DLI) published draft drug formulary and treatment guideline rules and amendments in early October.
The Growing Federal and State Challenges of Medical Marijuana
As of October 2018 a total of 29 states and the District of Columbia currently allow for medical marijuana and cannabis programs.